A Bioequivalence Study of Hetrombopag in Healthy Subjects

Clinical trial NCT05088655 · COMPLETED

Trial details

NCT number: NCT05088655
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sever Aplastic Anaemia

Start date: 2021-06-25
Primary completion: 2022-07-25
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.